The Centre of Research Excellence in Tuberculosis Control (TB-CRE) has held a seminar at the Centenary Institute in support of World TB Day, 24 March 2022. TB, primarily affecting the lungs, is one of the world’s deadliest infectious killers. Every day, over 4,100 people die from TB world-wide and nearly 30,000 people fall ill with ...

Australian cricketer Shane Warne tragically passed away from a suspected heart attack at the age of 52. In a new episode of the ‘Racing Heart’ podcast, produced by the National Centre for Sport Cardiology, Dr Jessica Orchard (Heart Foundation Postdoctoral Fellow at the Centenary Institute) and Associate Professor Andre La Gerche (Head of Sports Cardiology ...

Professor John Rasko AO, Head of the Gene and Stem Cell Therapy Program at the Centenary Institute features on a just launched episode of the ‘Festival of Dangerous Ideas (FODI): The In-Between’ podcast. The recently launched podcast series pairs 16 leading thinkers from around the globe having candid conversations that tackle the big issues of ...

World-leading research into pancreatic cancer has been boosted with the Centenary Institute’s Professor John Rasko AO awarded a $100,000 ‘Innovation in Early Detection’ grant from The Australian Pancreatic Cancer Foundation. One of the deadliest forms of cancer, the five-year survival rate for pancreatic cancer is less than 12% in Australia. A reason for the low ...

The Centenary Institute’s Dr Madeleine Gill has today received a National Health and Medical Research Council (NHMRC) postgraduate scholarships grant to continue her research into understanding unexplained heart failure in patients with liver cirrhosis. Cirrhotic cardiomyopathy affects approximately 50 per cent of patients with cirrhosis and can be a barrier to liver transplantation and is ...

Aster Pijning, PhD candidate at the ACRF Centenary Cancer Research Centre, has had her science recognised with an image from her paper selected for the recent front cover of the prestigious journal ÔBloodÕ.

Researchers from the Centenary UTS Centre for Inflammation and collaborators have been awarded a seed grant of $20,000 to advance a new treatment strategy for chronic obstructive pulmonary disease (COPD) patients suffering from influenza.

A team of Australian researchers, including from the Centenary Institute, has shown in a new study that older people and men tend to have higher levels of the enzyme ACE2 on the cells of their lower lungsÐand that this may be the reason for their increased risk from COVID-19.

Scientists in Australia have developed a method for the rapid synthesis of safe vaccines, an approach that can be used to test vaccine strategies against novel pandemic pathogens such as SARS-CoV-2, the virus that causes COVID-19.Ê

The first study of human gene associations with severe COVID-19 has just been accepted for publication in the highly prestigious journal ÔNatureÕ.

Research from the Centenary Institute has found that the human enzyme dipeptidyl peptidase (DPP4) does not bind to the spike protein of the SARS-CoV-2 virus and so cannot enable COVID-19 infection in our bodies.

The first case of COVID-19 reinfection has been documented by scientists from Hong Kong who report that a 33 year old man has been infected by two different strains of the virus. The second infection occurred more than four months after recovery from the first episode of the disease.